Fungemia during murine cryptococcosis sheds some light on pathophysiology

References

• Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995; 8: 515–548.
   PubMed Web of Science ®Google Scholar
• Lewis JL, Rabinovich S. The wide spectrum of cryptococcal infections. Am J Med 1972; 53: 315–322.
   PubMed Web of Science ®Google Scholar
• Dismukes WE, Cloud G, Gallis HA, et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. New Engl J Med 1987; 317: 334–341.
   PubMed Web of Science ®Google Scholar
• Chuck SL, Sande MA. Infections with Cryptococcus neofor-mans in the acquired immunodeficiency syndrome. New Engl J Med 1989; 321: 794–799.
   PubMed Web of Science ®Google Scholar
• Larsen RA, Leal MAE, Chan LS. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. Ann Intern Med 1990; 113: 183–187.
   Google Scholar
• Rozenbaum R, Rios Goncalves AJ. Clinical epidemiology study of 171 cases of cryptococcosis. Clin Infect Dis 1994; 18: 369–380.
   PubMed Web of Science ®Google Scholar
• Saag MS, Powderly WG, Cloud GA, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. New Engl J Med 1992; 326: 83–89.
   PubMed Web of Science ®Google Scholar
• Clark RA, Greer D, Atkinson W, Valainis GT, Hyslop N. Spectrum of Cryptococcus neoformans infection in 68 patients infected with human immunodeficiency virus. Rev Infect Dis 1990; 12: 768–777.
   Google Scholar
• Chechani V, Kamholz SL. Pulmonary manifestations of dis-seminated cryptococcosis in patients with AIDS. Chest 1990; 98: 1060–1066.
   PubMed Web of Science ®Google Scholar
• Diamond RD. Cryptococcus neoformans. In: Mandell GL, Ben-nett JE, Dolin R, eds. Mandell, Douglas and Bennett's. Princi-ples and Practice of Infectious Diseases. New York: Churchill Livingstone, 1995; 2331–2340.
   Google Scholar
• Kwon-Chung KJ, Bennett JE. Cryptococcosis. In: Kwon-Chung KJ, Bennett JE, eds. Medical Mycology. Philadelphia: Lea and Febiger, 1992; 397–446.
   Google Scholar
• Clemons KV, Brummer E, Stevens DA. Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis. Ant imicrob Agents Chemother 1994; 38: 460–464.
   Google Scholar
• Hong Nguyen M, Najvar LK, Yu CY, Graybill JR. Combina-tion therapy with fluconazole and flucytosine in the murine model of cryptococcal meningitis. Antimicrob Agents Chemother 1997; 41: 1120–1123.
   Google Scholar
• Mukherjee J, Zuckier LS, Scharff MD, Casadevall A. Thera-peutic efficacy of monoclonal antibodies to Cryptococcus ne-oformans glucuronoxylomannan alone and in combination with amphotericin B. Antimicrob Agents Chemother 1994; 38: 580–587.
   PubMed Web of Science ®Google Scholar
• Palou de Fernandez E, Mercedes Patino M, Graybill JR, Tarbit MH. Treatment of cryptococcal meningitis in mice with fluconazole. J Antimicrob Chemother 1986; 18: 261–270.
   Google Scholar
• Troke PF, Andrews RJ, Marriott MS, Richardson K. Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice. J Antimicrob Chemother 1987; 19: 663–670.
   PubMed Web of Science ®Google Scholar
• Velez JD, Allendoerfer R, Luther M, Rinaldi MG, Graybill JR. Correlation of in vitro azole susceptibility with in vivo response in a murine model of cryptococcal meningitis. J Infect Dis 1993; 168: 508–510.
   Google Scholar
• Dromer F, Charreire J. Improved amphotericin B (AMB) activ-ity by a monoclonal anti-Cryptococcus neoformans antibody. J Infect Dis 1991; 163: 1114–1120.
   PubMed Web of Science ®Google Scholar
• Macher AM, Bennett JE, Gadek JE, Frank MM. Complement depletion in cryptococcal sepsis. J Immunol 1978; 120: 1686–1690.
   PubMed Web of Science ®Google Scholar
• Graybill JR, Sobel J, Saag M, et al. Cerebrospinal fluid hyper-tension in patients with AIDS and cryptococcal meningitis. In: Program and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto. Washington, DC: American Society for Microbiology (I-153), 1997.
   Google Scholar
• Bille J, Stockman L, Roberts GD, Horstmeier CD, Ilstrup DM. Evaluation of a lysis-centrifugation system for recovery of yeasts and filamentous fungi from blood. J Clin Microbiol 1983; 18: 469–471.
   Google Scholar
• Wheat J. Endemic mycoses in AIDS: a clinical review. Clin Microbiol Rev 1995; 8: 146–159.
   PubMedGoogle Scholar
• Yagupsky P, Menegus MA. Cumulative positivity rates of multiple blood cultures for Mycobacterium avium-intracellulare and Cryptococcus neoformans in patients with the acquired immunodeficiency syndrome. Arch Pathol Lab Med 1990; 114: 923–925.
   PubMedGoogle Scholar
• Van der Horst CM, Saag MS, Cloud GA, et al. Treatment of cryptococcal meningitis associated with the acquired immune deficiency syndrome. New Engl J Med 1997; 337: 15–21.
   PubMed Web of Science ®Google Scholar
• Kovacs JA, Kovacs AA, Polis M, et al. Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med 1985; 103: 533–538.
   PubMed Web of Science ®Google Scholar